Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 54451-24-0
SID:
Drug Levels and Effects
Summary of Use during Lactation
No information is available on the use of lanthanum carbonate during breastfeeding in humans. In animal studies, lanthanum was deposited in the bones of juvenile animals. Lanthanum carbonate should not be used in nursing mothers. An alternate drug is recommended.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
Aluminum Hydroxide, Calcium Acetate, Calcium Carbonate, Ferric Citrate, Sevelamer, Sucroferric Oxyhydroxide
Substance Identification
Substance Name
Lanthanum Carbonate
CAS Registry Number
54451-24-0
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- Lanthanum carbonate, a potent and selective phosphate binder, is transported and absorbed mainly via M cells in gastrointestinal tract.[Metallomics. 2023]Lanthanum carbonate, a potent and selective phosphate binder, is transported and absorbed mainly via M cells in gastrointestinal tract.Huang HX, Liu HX, Yang XG. Metallomics. 2023 Jun 1; 15(6).
- Assessment of the application for renewal of authorisation of Lantharenol(®) (lanthanum carbonate octahydrate) for cats.[EFSA J. 2019]Assessment of the application for renewal of authorisation of Lantharenol(®) (lanthanum carbonate octahydrate) for cats.EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Bampidis V, Azimonti G, Bastos ML, Christensen H, Dusemund B, Kouba M, Kos Durjava M, López-Alonso M, López Puente S, et al. EFSA J. 2019 Jan; 17(1):e05542. Epub 2019 Jan 11.
- Review [Pharmacodynamic and pharmacokinetic profile of lanthanum carbonate].[Clin Calcium. 2009]Review [Pharmacodynamic and pharmacokinetic profile of lanthanum carbonate].Joki N. Clin Calcium. 2009 Feb; 19(2):213-8.
- Lanthanum carbonate (Fosrenol) efficacy and tolerability in the treatment of hyperphosphatemic patients with end-stage renal disease.[Clin Nephrol. 2005]Lanthanum carbonate (Fosrenol) efficacy and tolerability in the treatment of hyperphosphatemic patients with end-stage renal disease.Chiang SS, Chen JB, Yang WC. Clin Nephrol. 2005 Jun; 63(6):461-70.
- Review [Introduction to lanthanum carbonate: pharmacology, safety and tolerability].[Nefrologia. 2008]Review [Introduction to lanthanum carbonate: pharmacology, safety and tolerability].Rodríguez Portillo M. Nefrologia. 2008; 28 Suppl 5:7-10.
- Lanthanum Carbonate - Drugs and Lactation Database (LactMed®)Lanthanum Carbonate - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...